Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Kashiv BioSciences, LLC
EIR
•Kashiv BioSciences, LLC•November 21, 2017

Kashiv BioSciences, LLC – FDA EIR, Nov 21, 2017

Record Details

An FDA inspection of Adello Biologics, LLC.'s bulk drug substance manufacturing facility in Chicago, IL, took place from November 13-17 and 20-21, 2017. This inspection was conducted to support a Biologics License Application (BLA) for Theragrastim (a biosimilar to Neupogen) and followed regulatory frameworks outlined in Compliance Program 7356.002M and ICH Q7. At the conclusion, an amended six-item Form FDA 483 was issued to company management, detailing significant deficiencies. The main issues included inadequate quality oversight across operations, indicating potential systemic weaknesses in the quality management system. Inspectors also found insufficient laboratory procedures, which could compromise testing and data integrity. The firm's deviation investigation process was deemed inadequate, potentially hindering effective root cause analysis. Furthermore, there was inadequate control over critical materials, posing risks to product quality and supply chain. Lastly, the report cited issues with written procedures, noting that they were not consistently followed and were, in some cases, inherently insufficient. Adello Biologics, LLC. is required to address these observations comprehensively to ensure compliance with pharmaceutical manufacturing regulations.

Company
Kashiv BioSciences, LLC
Inspection date
November 21, 2017
Product type
biologics
Office
Chicago District Office
People
  • Kathleen R. Jones (investigator)
  • Brian D. Nicholson
  • Diane Raccasi
  • Tracy Denison (investigator)
  • Merry Christie (investigator)
View Company Profile

ID · 205f5afe-9806-49d3-9676-ae5605feb57b

Violation Codes1
21 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Kashiv BioSciences, LLC
  • 483 - 2024-06-14June 14, 2024
  • 483 - 2022-11-21November 21, 2022
  • 483 - 2022-01-14January 14, 2022
  • 483 - 2019-03-12March 12, 2019
  • EIR - 2019-03-12March 12, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kashiv BioSciences, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.